Tumor samples with high DUSP18 expression had lower immune-related indicators scores (Supplementary Fig. 9a–d), lower tumor mutation burden, microsatellite instability, tumor neoantigens and mutant-allele tumor heterogeneity (Supplementary Fig. 9e). Here, DUSP18 is linked to neoplasm.